Matt Hewitt
Stock Analyst at Craig-Hallum
(0.69)
# 2350
Out of 5,347 analysts
54
Total ratings
46.15%
Success rate
-0.74%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CSBR Champions Oncology | Maintains: Strong Buy | 8 12 | 5.94 | 102.02% | 4 | Mar 12, 2025 | |
BLFS BioLife Solns | Maintains: Strong Buy | 30 32 | 21.87 | 46.32% | 4 | Nov 13, 2024 | |
OMCL Omnicell | Maintains: Strong Buy | 45 64 | 30.37 | 110.73% | 5 | Oct 31, 2024 | |
LGND Ligand Pharmaceutica... | Maintains: Strong Buy | 135 140 | 102.05 | 37.19% | 3 | Jul 9, 2024 | |
SLP Simulations Plus | Reiterates: Buy | 56 56 | 31.82 | 75.99% | 7 | Jul 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 2.6 | 284.62% | 3 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 30 | 21.61 | 38.82% | 3 | May 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Jan 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 16 | n/a | n/a | 4 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 2.39 | 192.89% | 1 | Nov 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 207 200 | 118.06 | 69.41% | 3 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.27 | 687.4% | 1 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 5 2 | n/a | n/a | 2 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 2 | n/a | n/a | 1 | May 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 67 30 | 6.92 | 333.53% | 5 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 400 | 1.27 | 31396.06% | 1 | Jan 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 21 30 | n/a | n/a | 3 | Jul 28, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Jul 24, 2017 |